Search results
GLOBAL STRATEGY FOR PREVENTION, DIAGNOSIS AND MANAGEMENT OF COPD: 2024 Report. Evidence-based strategy document for COPD diagnosis, management, and prevention, with citations from the scientific literature. View the 2024 Summary of Changes. Download 2024 GOLD Report.
12 lut 2021 · We discuss the pathophysiology of COPD; describe COPD risk factors, signs, and symptoms that may facilitate earlier diagnosis of COPD; and reinforce the importance of spirometry use in establishing the diagnosis of COPD. Disease monitoring, as well as a review of the 2020 GOLD treatment recommendations, is also discussed.
12 lut 2021 · In this review, we provide an overview of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2020 report, with a focus on the management of COPD in the primary care setting. We discuss the pathophysiology of COPD; describe COPD risk factors, signs, and symptoms that may facilitate earlier diagnosis of COPD; and reinforce the ...
GOLD 2023 defines COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, expectoration and/or exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction. PATHOGENESIS: CAUSES AND RISK FACTORS.
30 lis 2022 · On Nov 14, 2022, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) published their 2023 global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (COPD).
10 sty 2024 · The GOLD report, which was initially released in 2001, offers scientifically backed guidance on COPD diagnosis, stable disease management, handling of exacerbations, and comorbidities . Healthcare professionals following GOLD recommendations may improve COPD outcomes and reduce resource utilization [ 3 , 4 ].
26 maj 2023 · Here, we provide a summary of the GOLD 2023 recommendations that highlights those aspects of more interest for practicing cardiologists dealing with patients with CVD who may suffer COPD.
